Loading clinical trials...
Loading clinical trials...
Test the hypothesis that increasing doses of CP-866,087 will decrease the total number of drinks consumed during a 2 hour acute alcohol consumption assessment and to determine the safety and tolerabil...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06676059 · Alcoholism, Substance-Related Disorders
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more
NCT04773691 · Alcoholism, rTMS Stimulation
NCT06916754 · Alcohol-Related Disorders, Alcoholism, and more
Pfizer Investigational Site
Cerritos, California
Pfizer Investigational Site
New Haven, Connecticut
Pfizer Investigational Site
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions